AQR Capital Management’s Nutex Health NUTX Stock Holding History

AQR Capital Management’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-728	Closed	-$164K	–	2253
2022 Q3	$164K	Buy	+728	New	+$309K	﹤0.01%	2072

Other funds holding NUTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

AQR Capital Management's NUTX Position: Q4 2022 in Review

AQR Capital Management sold out of Nutex Health (NUTX) in Q4 2022, closing a stake of 728 shares — an estimated $164K sold.

AQR Capital Management first reported a position in NUTX in Q3 2022 and held it in 1 quarter. The position peaked at $164K in Q3 2022. 76 funds tracked by Wall St. Rank hold NUTX as of Q4 2022.

AQR Capital Management reported no remaining Nutex Health position as of Q4 2022 after selling out during the quarter.
AQR Capital Management sold 728 Nutex Health shares in Q4 2022, an estimated $164K.
AQR Capital Management first reported a position in Nutex Health in Q3 2022 and held it in 1 quarter.
AQR Capital Management's Nutex Health position peaked at $164K in Q3 2022.
76 funds tracked by Wall St. Rank held Nutex Health as of Q4 2022.

Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.